CTHIn ForceLegislation
Private Health Insurance (Medical Devices and Human Tissue Products) Rules (No. 2) 2026
//
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
Private Health Insurance (Medical Devices and Human Tissue Products) Rules (No. 2) 2026
Start here
Turn the raw legal text into a practical explanation grounded in Private Health Insurance (Medical Devices and Human Tissue Products) Rules (No. 2) 2026.
This Division applies to the following decisions (reviewable decisions) of the Minister: (a) a decision that the Minister is satisfied as mentioned in paragraph 17(1)(b) that an application requires a clinical assessment; (b) a decision that the Minister is satisfied as mentioned in paragraph 18(1)(b) that an application requires an economic assessment; (c) a decision that the Minister is satisfied as mentioned in paragraph 19(1)(b) that an application requires a full health technology assessment; (d) a decision to refuse to agree to an application under subsection 22(5) for a refund of the whole or part of a cost‑recovery fee; (e) a decision to refuse to agree to a request under subsection 23(2) for the waiver of a cost‑recovery fee.
Note: The decision could be made by a delegate of the Minister (see section 333‑1 of the Act).